Ingrezza and Olanzapine drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ingrezza (valbenazine tosylate) and Olanzapine (olanzapine). Common drug interactions include asthenia among females and tremor among males.
The phase IV clinical study analyzes what interactions people have when they take Ingrezza and Olanzapine. It is created by eHealthMe based on reports of 232 people who take the same drugs from the FDA, and is updated regularly.
What is Ingrezza?
Ingrezza has active ingredients of valbenazine tosylate. eHealthMe is studying from 23,666 Ingrezza users. Check the latest studies of Ingrezza.
What is Olanzapine?
Olanzapine has active ingredients of olanzapine. It is often used in bipolar disorder. eHealthMe is studying from 69,242 Olanzapine users. Check the latest studies of Olanzapine.
232 people who take Ingrezza and Olanzapine together, and have interactions are studied.
What are the common drug interactions of Ingrezza and Olanzapine, by gender? *
What are the common drug interactions of Ingrezza and Olanzapine, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Ingrezza and Olanzapine?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ingrezza (23,666 reports)
- Olanzapine (69,242 reports)
Browse all drug interactions of Ingrezza and Olanzapine:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ingrezza:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Olanzapine:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ingrezza and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Olanzapine and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
- Gupta SK, Shwetank B, "Reversible bilateral sensori-neural hearing loss due to olanzapine in a male suffering from bipolar affective disorder", Indian journal of pharmacology, 2014 Jan .
- Og?odek E, Szota A, Araszkiewicz A, "Olanzapine-induced neuroleptic malignant syndrome after 10 years of treatment", Aust NZJ Psychiatry, 2013 Oct .
How the study uses the data?
The study uses data from the FDA. It is based on valbenazine tosylate and olanzapine (the active ingredients of Ingrezza and Olanzapine, respectively), and Ingrezza and Olanzapine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cialis cause Coronary Arterial Stent Insertion? - a second ago
- Could Perforomist cause Herpes Zoster? - 2 seconds ago
- Drug interactions of Prochlorperazine Maleate and Zykadia - 6 seconds ago
- Could Bentyl cause Infusion Site Erythema? - 12 seconds ago
- Drug interactions of Aztreonam and Renvela - 18 seconds ago
- Could Terazosin Hydrochloride cause Lung Infiltration? - 21 seconds ago
- Drug interactions of Triamcinolone Acetonide and Lisinopril - 23 seconds ago
- Could Benicar cause Hypoaesthesia Oral? - 26 seconds ago
- Drug interactions of Mercaptopurine and Vistaril - 35 seconds ago
- Could Lisinopril cause Stress Cardiomyopathy? - 42 seconds ago